Literature DB >> 9560499

Prospective audit of 200 patients undergoing laparoscopic inguinal hernia repair with follow-up from 1 to 4 years.

P Kiruparan1, S H Pettit.   

Abstract

The results of 215 laparoscopic transabdominal pre-peritoneal inguinal hernia repairs are reported with a follow-up of 1-4 years (median 2.5 years). The patients" age range was 17-85 (median 59 years). Three recurrences occurred in the first 75 repairs, where a 12 x 7 cm mesh was used. There has been no recurrence in the subsequent 140 repairs where a larger 15 x 10 cm mesh was used for the repair. A total of 5% of patients developed urinary retention after the operation and a further 13% developed minor complications. The procedure was remarkably pain-free, with 25% requiring no analgesia after the operation and 67% requiring no analgesia after discharge from hospital. There was a rapid return to normal activity, with 55% driving within 1 week of the operation and 85% within 2 weeks. Sixty per cent returned to work within 2 weeks of the operation and 69% within 3 weeks. Forty-two of the patients had undergone a previous open hernia repair and 93% of these preferred the laparoscopic repair as there was less post-operative pain and a quicker recovery. The results show that laparoscopic hernia repair is remarkably pain-free, allows a rapid return to normal activity and has a low recurrence rate when a 15 x 10 cm mesh is used.

Entities:  

Mesh:

Year:  1998        PMID: 9560499

Source DB:  PubMed          Journal:  J R Coll Surg Edinb        ISSN: 0035-8835


  2 in total

1.  Transabdominal pre-peritoneal inguinal hernia repair with external fixation.

Authors:  M S Abdelhamid
Journal:  Hernia       Date:  2011-02-11       Impact factor: 4.739

2.  The evaluation of the peak flow velocity and cross-sectional area of the femoral artery and vein following totally extraperitoneal vs preperitoneal open repair of inguinal hernias.

Authors:  M M Ozmen; N Ozalp; B Zulfikaroglu; P Soydinc; I Ziraman; S Hengirmen
Journal:  Hernia       Date:  2004-12       Impact factor: 4.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.